388 related articles for article (PubMed ID: 26519284)
21. [Advances in clinical differentiation between immunological and drug-induced liver injury].
Wang Y; Li YN; Zhang J; Wang BM; Zhou L
Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):717-720. PubMed ID: 29108197
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics of Patients with Drug-induced Liver Injury.
Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
[TBL] [Abstract][Full Text] [Related]
23. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
24. Necrotic cell death and suppression of T-cell immunity characterized acute liver failure due to drug-induced liver injury.
Kakisaka K; Kataoka K; Suzuki Y; Okada Y; Yoshida Y; Kuroda H; Takikawa Y
Cytokine; 2016 Oct; 86():21-28. PubMed ID: 27442007
[TBL] [Abstract][Full Text] [Related]
25. Two-step progression of varenicline-induced autoimmune hepatitis.
Sakakibara M; Ohkawa K; Nawa T; Abe Y; Kusakabe A; Imai T; Katayama K
Clin J Gastroenterol; 2018 Jun; 11(3):184-187. PubMed ID: 29383494
[TBL] [Abstract][Full Text] [Related]
26. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital.
Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G
Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873
[TBL] [Abstract][Full Text] [Related]
27. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis.
Kuzu UB; Öztaş E; Turhan N; Saygili F; Suna N; Yildiz H; Kaplan M; Akpinar MY; Akdoğan M; Kaçar S; Kiliç ZM; Köksal AŞ; Ödemiş B; Kayaçetin E
Hepatol Res; 2016 Apr; 46(4):277-91. PubMed ID: 25926402
[TBL] [Abstract][Full Text] [Related]
28. Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis.
Efe C; Ozaslan E; Purnak T; Ozseker B; Kav T; Bayraktar Y
Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):185-8. PubMed ID: 21974938
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic profiling for drug-induced liver injury with autoantibodies.
Han YZ; Ma ZT; Zhou MX; Niu M; Zhao X; Guo YM; Song XH; Lu YW; Bai ZF; Li Z; Gao H; Zhao YK; Wang JB; Xiao XH; Jing J
Int Immunopharmacol; 2022 Oct; 111():109084. PubMed ID: 35932613
[TBL] [Abstract][Full Text] [Related]
30. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
31. Drug induced liver injury with analysis of alternative causes as confounding variables.
Teschke R; Danan G
Br J Clin Pharmacol; 2018 Jul; 84(7):1467-1477. PubMed ID: 29607530
[TBL] [Abstract][Full Text] [Related]
32. Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.
Zhu Y; Niu M; Chen J; Zou ZS; Ma ZJ; Liu SH; Wang RL; He TT; Song HB; Wang ZX; Pu SB; Ma X; Wang LF; Bai ZF; Zhao YL; Li YG; Wang JB; Xiao XH;
J Gastroenterol Hepatol; 2016 Aug; 31(8):1476-82. PubMed ID: 26896664
[TBL] [Abstract][Full Text] [Related]
33. A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.
Morii K; Nishisaka M; Nakamura S; Oda T; Aoyama Y; Yamamoto T; Kishida H; Okushin H; Uesaka K
J Clin Pharm Ther; 2014 Oct; 39(5):573-6. PubMed ID: 24989642
[TBL] [Abstract][Full Text] [Related]
34. Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury.
Kumar A; Sood V; Khanna R; Verma SK; Mehra N; Rawat D; Alam S
Indian J Pediatr; 2018 Aug; 85(8):676-678. PubMed ID: 29247427
[TBL] [Abstract][Full Text] [Related]
35. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
36. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.
Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ
World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of a liver biopsy in patients with an acute liver failure or acute liver injury.
Hunyady P; Herrmann E; Bojunga J; Friedrich-Rust M; Pathil A; Zeuzem S; Mihm U
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):801-806. PubMed ID: 35482907
[TBL] [Abstract][Full Text] [Related]
39. The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury.
He T; Ren L; Gong M; Guo Y; Wang L; Xiao X; Wang R; Bai Z
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102009. PubMed ID: 35977662
[TBL] [Abstract][Full Text] [Related]
40. The etiology and differential diagnosis of "autoimmune hepatitis-like liver disease" in children: a single-center retrospective study.
Ma D; Liu X; Ai G; Pan W; Liu L; Huang Y; Liao Y; Lu Y; Zhang Z; Zhou H; Huang Z; Hao X; Shu S; Fang F
Front Pediatr; 2024; 12():1377333. PubMed ID: 38818349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
